ID: MRFR/HC/6736-CR | August 2019 | Region: Global | 113 pages
Stroke Post Processing Software Market is projected to list a CAGR of 6.48% to influence income generation of USD 1,294.24 Million by 2024. A stroke can be defined as the absence of blood flow to brain tissues, resulting in vascular assembly within the brain. Furthermore, increasing awareness regarding the benefit of stroke post-processing software in individuals and healthcare professionals would create more demand for these products, boosting the global stroke post-processing software market's growth.
The effect of the COVID-19 pandemic on medical care for circumstances other than COVID-19 has been problematic to quantify. Any reduction in patients' upkeep with severe conditions such as ischemic stroke may be noteworthy because timely treatment may decrease the incidence of disability. The decline in the use of stroke imaging from the pre-pandemic period to the early-pandemic period data supports an association between COVID-19 and stroke in young residents without characteristic vascular risk influences, at times with only slight respiratory symptoms, are growing. Severe stroke care requires real-time, specialist-led medication decisions, together with thrombolysis and recommendation for mechanical thrombectomy. The pathways intended to produce time-critical interventions for stroke patients are under intense pressure owing to the bearing of the COVID-19 pandemic. In responding to this unparalleled drain on acute care facilities, stroke clinicians are trying to reconfigure current clinical pathways both in and among hospitals. The integration of artificial intelligence and digital communication support into clinical pathways offers a chance to mitigate acute stroke care interruption.
Collaborations Between Start-Up Companies & Big Market Players
The joining of market players' efficiencies is estimated to introductions of more effective products to treat the ailment in the coming years.
Increasing Burden of Ischemic Strokes
The increased occurrence of cases related to ischemic strokes is estimated to motivate the stroke post-processing software market size in the impending period.
Growth in Aging Population
The surge in geriatric population levels globally is foreseen to promote the stroke post processing software market growth in the impending period.
Stringent Regulatory Policies
The presence of rigorous regulations related to medical treatment is foreseen to impel the forecast period's market expansion.
Entering Developing Economies
The innovations in developing nations are estimated to promote the international market's advancement in the forecast period.
The surge in mobile phoneprenetration is predicted to bolster the global market.
The increased CT scan requirements are likely to create an impetus for the segment, leading it to the market's top position.
The accelerated occurrence of ischemic strokes is estimated to improve the segment's position as the overall market leader.
The hospitals and clinics segment accounted for USD 479.89 million in 2018 and is likely to enhance the segment in the future.
Europe To Hold Global Market Dominance
Europe is anticipated to hold the principal portion of the global stroke post processing software market. This is owing to the presence of a well-developed healthcare structure. Moreover, European companies offering stroke post processing software are getting involved in collaborations, mergers, and product launches to gain more market share, which positively affects stroke post-processing software market trends.
Established Setup To Promote Advancement Of North America
Americas showed a considerable increase in the market due to an established healthcare system and two major stroke post processing software companies in the US.
Surge In Ailments To Buttress APAC Market
The Asia Pacific is estimated to be the fastest rising region globally due to rapidly emerging frugalities in the region. Similarly, the accessibility of scientific know-how in the Asia Pacific is likely to back the market growth. The large patient pool for heart diseases in Asia Pacific creates additional opportunities for market growth. Japan held a share of 28.5% in the Asia-Pacific stroke post processing software market in 2018.
The well-known companies in the Stroke Post Processing Software Market are:
Nov 2020 Royal Philips, a health technology leader, declared the subsequent generation of Philips Advanced Visualization Workspace IntelliSpace Portal includes a healthy set of new AI-assisted quantitative measurement and automatic results generation features to backing the diagnostic workflow, including follow-up and communication through several areas. Its AI-assisted pulmonary competencies consist of the evaluation of complex lung conditions related to COVID-19. CT Brain Perfusion Analysis – IntelliSpace Portal 12 now helps automatic brain perfusion capacities promptly accessible on PACS with the possibility of automatically emailing perfusion consequences to a stroke patient's clinicians in two minutes to decrease door-to-needle time.
Oct 2020 GE Healthcare presented Edison HealthLink, new edge computing technology intended explicitly for health care providers' requirements that permits clinicians to analyze, collect, and act upon critical data closer to its origin. While COVID-19 has enhanced cloud technology adoption, examining data from a distance can pose numerous risks to operational effectiveness and patient care. The concerns around bandwidth and latency tests remain that could determine a patient's outcome.
Oct 2020 A mHealth app advanced by investigators at Houston Methodist Hospital and Penn State reportedly can classify a stroke from a user's speech and facial schedules. The app, which can be downloaded on an electronic device, uses AI to recognize a stroke's signs and has been proven as precise as an emergency room assessment. The record for the app was collected from incidents of more than 80 patients with stroke indications. Researchers stated an accuracy rate of 79 % in testing the app, which they pronounced is similar to an exam by an ER doctor through a CT scan.
Nov 2020 AstraZeneca declared the FDA accepted its P2Y12 inhibitor ticagrelor to decrease stroke risk among patients with severe ischemic stroke or high-risk transient ischemic bout. The initial indication for ticagrelor (Brilinta) was arranged based on optimistic results from the THALES phase 3 trial.
Frequently Asked Questions (FAQ) :
The CAGR for the market would be 6.48% for the forecast period.
The market would reach a valuation of USD 1294.24 million.
The segment had a valuation of USD 479.89 million in 2018.
The Asia Pacific is the fastest-growing Stroke Post Processing Software Market.
Europe is the largest regional Stroke Post Processing Software Market.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.